Cathie Wood’s ARK Invest Buys Over 630,000 Shares of Palantir
A couple of Cathie Wood's Ark Invest exchange-traded funds purchased over 630,000 shares of Palantir on January 10.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Monday. Specifically, these funds bought over 630,000 shares of Palantir Technologies Inc. (NASDAQ: PLTR | PLTR Price Prediction) altogether, as the price of these ETFs were down on the day. Note that they are down a fair amount in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) bought 43,400 shares of Palantir and ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) bought 591,571 shares. At Monday’s closing price, this would have valued these purchases at roughly $10.5 million. Even though this is a small fraction of the total holdings, every little bit counts. The innovation fund is down 38% in the past year and the other is down 13%.
Check out all of ARK Invest’s purchases for Monday as well:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | COIN | COINBASE GLOBAL | 57,223 |
| ARKF | PATH | UIPATH | 242,567 |
| ARKF | TWLO | TWILIO | 41,304 |
| ARKF | SE | SEA | 49,913 |
| ARKF | HOOD | ROBINHOOD MARKETS | 298,961 |
| ARKF | DKNG | DRAFTKINGS | 176,579 |
| ARKF | TDOC | TELADOC HEALTH | 13,200 |
| ARKF | SQ | BLOCK | 6,600 |
| ARKG | EXAS | EXACT SCIENCES | 49,498 |
| ARKG | TDOC | TELADOC HEALTH | 31,800 |
| ARKG | NRIX | NURIX THERAPEUTICS | 61,324 |
| ARKG | BNR | BURNING ROCK BIOTECH | 54,800 |
| ARKG | DNA | GINKGO BIOWORKS | 50,000 |
| ARKG | NVTA | INVITAE | 21,900 |
| ARKG | QSI | QUANTUM-SI | 9,614 |
| ARKK | COIN | COINBASE GLOBAL | 86,295 |
| ARKK | TDOC | TELADOC HEALTH | 101,100 |
| ARKK | DNA | GINKGO BIOWORKS | 269,581 |
| ARKK | SQ | BLOCK | 11,910 |
| ARKK | NVTA | INVITAE | 69,400 |
| ARKK | PLTR | PALANTIR TECHNOLOGIES | 43,400 |
| ARKK | HOOD | ROBINHOOD MARKETS | 21,000 |
| ARKQ | PATH | UIPATH | 409,351 |
| ARKQ | TSP | TUSIMPLE | 401,538 |
| ARKQ | PLTR | PALANTIR TECHNOLOGIES | 591,571 |
| ARKQ | AVAV | AEROVIRONMENT | 18,583 |
| ARKQ | XPEV | XPENG | 14,859 |
| ARKQ | DDD | 3D SYSTEMS | 30,015 |
| ARKQ | SSYS | STRATASYS | 23,800 |
| ARKQ | MKFG | MARKFORGED | 47,455 |
| ARKW | TDOC | TELADOC HEALTH | 23,400 |
| ARKW | VUZI | VUZIX | 117,333 |
| ARKX | PATH | UIPATH | 28,137 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
